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**O**ver the past few decades, improved care for premature infants has led to a significant increase in their survival rates, especially in infants born with a weight less than 1000 g. Therefore, more attention is currently being paid to improving the long-term outcome and quality of life among such infants.^[@ref1]^ The normal growth of the fetus in the womb is very rapid. For example, from the week 30 to 36 of gestation, the fetus's body weight doubles and there will be a significant differentiation in tissues. Providing quality and quantitative growth is a major challenge in infants whose nutritional linkage through funiculus is cut off prematurely. The purpose of feeding such infants is to keep their growth at the same rate as the intrauterine process.^[@ref2]^ These infants have higher nutritional needs compared to term infants. Energy and protein are the two important factors that affect growth, thus, one of the key goals of nutrition management is to facilitate their absorption.^[@ref3]^ The newborn infants not received any protein will have a negative nitrogen balance and lose up to 1% of their protein reserves every day.^[@ref4]^ In addition, recent studies report that insulin levels drop when there is amino acid deficiency, leading to hyperglycemia and hyperkalemia.^[@ref5],[@ref6]^ On the other hand, the best food for premature infants is the breast milk. Other benefits of breastfeeding, in addition to nutritional benefits, include protecting the infant from many infections, reducing sudden death syndrome and possibly long-term effects such as: lower risk of childhood or adolescent obesity and improved outcome of neurodevelopment.^[@ref7]^ Therefore, after achievement of breast milk volume to 120 ml/kg of body weight, Human Milk Fortifier is recommended to be used to enhance breast milk with protein, calcium and phosphorus until infant weight reaches 2500 g.^[@ref8]^ Furthermore, premature infants are subjected to physical growth retardation, metabolic abnormalities, and neurodevelopmental delay. This is while the amount of protein and other nutrients in breast milk is not enough to meet the extremely high needs of Very Low Birth Weight (VLBW) infants. Developmental failure is a common problem among the VLBW infants who are breastfed only.^[@ref9]^ Ectopic growth restriction among infants with Extremely Low Birth Weight (ELBW) during admission to the Neonatal Intensive Care Unit (NICU) is a negative prognostic factor for long-term outcomes. Among ELBW infants, complementary nutrition should be given for growth to be equal to fetuses of similar gestational age. Proper growth and development (specifically in the brain) is dependent on protein intake.^[@ref12],[@ref25]^ Given to whatever mentioned above, the necessity of VLBW infants' nutrition (breast milk plus complementary protein) and also the threats of renal dysfunctions among such infants as well as very limited investigations conducted in this field, the aim of this study was to investigate the long term impact of protein supplementation on renal function of under 1200g bearth weighing infants in the third year of birth. This study was based on a RCT (was registered in IRCT) that designed to investigate the growth of newborns following supplemental protein used and the results was mentioned in a previous article,^[@ref14]^ and after three years we designed the present study to evaluate the renal functional outcomes in that babies.

Materials and Methods {#sec1-1}
=====================

The present study is a clinical trial where infants weighing less than 1200 grams born at Akbar Abadi Hospital in 2014-15 (at the time of study, they were 3 years old) were investigated in two groups, one group being breast-fed plus HMF as well as complementary protein and the other group was fed by breast milk plus HMF. Intake of protein powder was 0.6-0.8g/day, whose brand is not mentioned due to the advertising aspect. They have received protein supplementation at the course of NICU hospitalization, protein was added to maternal milk when the amount of milk reaches to 100 cc/kg/day, at this time parenteral nutrition was discontinued and the volume of feeding was increased 20cc/kg/day until reached to 150-180cc/kg/day. The fortification and the protein supplementation were stopped when the weight of the baby reached to 1500 grams The protein intake in all infants in the intervention group was the same and from one brand in our study. The control group was fed similar to the intervention group but had received no complementary protein. The inclusion criteria for participants were as follows: Birth weight less than 1200 in 2014-15, having parents' consent for participation and regular presence in the test sessions. The exclusion criterions were: To suffer a major disease preventing to achieve data, such as asphyxia, renal anomaly, cardiac anomaly, severe sepsis, necrotizing enterocolitis and renal failure at the time of hospitalization. The sample size was not required to be calculated in this study since renal function would be evaluated over a specified period of one year (age 3). The number of infants mentioned in the above two groups was in total 70 in 2014-15, but in this study, the numbers dropped to two groups of 18. Indeed, we encountered drop of subjects due to several reasons, e.g., lack of access to infants, mistakes in call numbers, etc. As a result, 18 infants in each group were randomly enrolled in the present study. In the given day, the children were examined by the appropriate physician and their height and weight were measured. Afterwards, the relevant tests (BUN, Cr, U/A, Alb) were conducted at the hospital laboratory. These tests were considered to evaluate the renal function of the children at the age of 3 years with regard to protein intake during infancy. Each test is described briefly as follows:
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-   BUN, or Blood Urea Nitrogen test, measures the amount of urea nitrogen in the blood, showing how the kidneys work \[[@ref21]\].

-   Cr: Creatinine is a protein produced by metabolism in the muscles, which is excreted by the kidneys, and in association with BUN, helps evaluating renal function \[[@ref22]\].

-   Alb: Albumin is one of the proteins in the plasma that is produced by the liver. In renal failure, due to lack of protein reabsorption, it decreases in the blood \[[@ref23]\].

-   U/A: Urine analysis (urinalysis) for kidney tests \[[@ref24]\]

At the final step, after data collection, it was coded and imported into the software package SPSS Ver.22 for analysis. The results were expressed as mean and standard deviation (mean ± SD) for the quantitative variables and as percentages for the qualitative variables. Significance level was set to be less than 0.05. All patient data were analyzed by the statistical software as well as by chi-square and T-student statistical tests.
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Results {#sec1-2}
=======

Demography and general specifications {#sec2-1}
-------------------------------------

30.56% and 69.44% of the cases were girls and boys, respectively. 42.77%, 36.11% and 16.61% of the cases were in the age 14-24 months, 24-34 months and 34-44 months, respectively. Cesarean delivery had been applied for all infants. At their birth, 22.22%, 50% and 27.78% of the babies had a weight of 750-900g, 900-1050g and 1050-1200g, respectively. In terms of their current weight, 11.11% of patients who received protein (intervention group) and 25% of those without protein intake (control group) were in the percentile 0-5. Also, 5.56% of intervention group members and 8.33% of controls were in the percentile 5-10. Additionally, 16.67% of the protein recipients were in the percentile 10-25. 11.11% of the former group and 8.33% of the latter group were in the percentile 25-50. Finally, 5.56% of the intervention group members were in the percentile 75-90 ([Figure 1](#fig001){ref-type="fig"}). In terms of their current height, 16.67% of the intervention group members and 5.56% of the control group members were in the percentile 0-5. of the babies had a weight of 750-900g, 900-1050g and 1050-1200g, respectively. In terms of their current weight, 11.11% of patients who received protein (intervention group) and 25% of those without protein intake (control group) were in the percentile 0-5. Also, 5.56% of intervention group members and 8.33% of controls were in the percentile 5-10. Additionally, 16.67% of the protein recipients were in the percentile 10-25. 11.11% of the former group and 8.33% of the latter group were in the percentile 25-50. Finally, 5.56% of the intervention group members were in the percentile 75-90 ([Figure 1](#fig001){ref-type="fig"}). In terms of their current height, 16.67% of the intervention group members and 5.56% of the control group members were in the percentile 0-5. 16.67% of those received protein and 8.33% of those without protein intake were in the percentile 10-25. 5.56% of the former group members and 8.33% of the latter were in the percentile 10-25. Lastly, 16.67% of those received protein and 16.67% of the controls were in the percentile 50-75 ([Figure 2](#fig002){ref-type="fig"}). In the realm of head circumference, about 11.11% of those, who received the protein and 8.33% of those without protein intake were in the percentile 0-5. 5.56% of protein recipients and 16.67% of non-protein recipients were in the percentile 5-10. 11.11% of the intervention group members and 8.33% of the control group members were in the percentile 25-50. In the percentile 50-70 there 8.33% of the non-protein recipients. In the percentile 75-90 were 11.11% of those, who received protein ([Figure 3](#fig003){ref-type="fig"}).

###### 

presents the results of BUN test in both control and intervention groups. P = 0.010

  ----- -------------- ---- ------- ---------------- -----------------
        Group          N    Mean    Std. Deviation   Std. Error Mean
  BUN   Intervention   18   16.67   4.875            1.149
        Control        18   13.00   2.910            .686
  ----- -------------- ---- ------- ---------------- -----------------

###### 

presents the results of Creatine test in both control and intervention groups. P = 0.766

  ------------ -------------- ---- ------ ---------------- -----------------
               Group          N    Mean   Std. Deviation   Std. Error Mean
  Creatinine   Intervention   18   .800   .2000            .0471
               Control        18   .783   .1249            .0294
  ------------ -------------- ---- ------ ---------------- -----------------

###### 

presents the results of Albumine test in both control and intervention groups. P = 0.257

  --------- -------------- ---- ------- ---------------- -----------------
            PRintake       N    Mean    Std. Deviation   Std. Error Mean
  Albumin   Intervention   18   4.456   .3468            .0817
            Control        18   4.600   .4029            .0950
  --------- -------------- ---- ------- ---------------- -----------------

###### 

presents the results of Urinalaysis (U/A) test in both control and intervention groups. PRintake \* Urinalaysis Crosstabulation

  ------- -------------- ------------- -------
  Count                  Urinalaysis   
                         Normal        Total
  Group   Intervention   18            18
          Control        18            18
  Total                  36            36
  ------- -------------- ------------- -------

According to the table above, the U/A was normal in both groups and no significant relationship was observed between the two groups. Given the normality of U/A, the p-value was not calculated.

The results of each test were elaborated individually as presented in the [Tables 1](#table001){ref-type="table"} to 4. Considering the obtained P-value, there is a significant relationship between BUN and protein intake among ELBW infants. The mean value of intervention group was significantly higher than that of controls. There was no significant relationship between Cr content and protein intake among ELBW infants with respect to the obtained p-value. According to the UPPER and LOWER limits, the first one was positive and the second was negative, the mean values of the two groups were not significantly correlated and were relatively equal. According to the obtained p-value, there was an insignificant relationship between ALB and protein intake among ELBW infants. According to the UPPER and LOWER limits, the first one was positive and the second was negative and the mean values of the two groups were not significantly correlated and were relatively equal. According to the table above, the U/A was normal in both groups and no significant relationship was observed between the two groups. Also, given the normality of U/A, the p-value was not calculated.

Discussion {#sec1-3}
==========

In the present clinical trial, we evaluated the long-term consequences of supplementary protein intake on renal function of VLBW children. Three years after protein administration, these children's renal function was reevaluated. The intervention and control groups were matched according to the corresponding variables. The former group was composed of those, who have taken supplementary protein and the latter did not have such an experience. This evaluation was undertaken at age 3 yearso. From one hand, the necessity of protein intake as a supplementary has been proved beneficial for ELBW infants,^[@ref13],[@ref14],[@ref25]^ but from another hand the renal function of premature and ELBW infants is of high importance since cases of renal dysfunction and decreased kidney size have been described after birth of premature and ELBW infants.^[@ref20]^ However, to the best of our knowledge very low or even no study has been published to test if protein intake can make a significant impact on renal function of such babies. To this aim, four special tests of renal function assessment were chosen and conducted to answer the research question. Recent studies report that feeding premature infants with protein-rich diets will be accompanied by positive nitrogen balance, enhancing protein synthesis in the body, improving postnatal growth, improving cognitive function, and improving brain development.^[@ref13],[@ref25]^ Kashaki et al.,^[@ref14]^ undertook an investigation on ELBW infants, where the infants were divided into two groups, randomly assigned to the group receiving diet containing supplemental protein and the other group receiving no proteins. Their findings indicated that the former group had better growth.^[@ref14]^ Also, in a similar study, Mariani et al.,^[@ref15]^ reported that the increased content of protein intake in breast milk can result in short/long-term profits in the realm of neurodevelopment and growth among ELBW infants. Additionally, William argues that improving preterm infants' nutrition, either intravenous or enteral, following to the birth, will enhance protein balance and positive energy and also will promote longer neurodevelopmental results. Such profits were permanent, specifically to prevent chronic diseases.^[@ref15]^ Accordingly, Morgan et al. reported that early and more energy and protein intake will result in faster head growth and enhanced head circumference among preterm infants.^[@ref16]^ Meanwhile, Kumar and Sundaram found that breast milk cannot merely meet preterm infants' severe nutrient needs including vitamins, proteins, minerals, energy and trace elements.^[@ref17]^ Ken et al., conducted a retrospective study in Osaca medical center. They evaluated the corrected BUN (CBUN) in the third year of birth among ELBW children in two groups according to Developmental Quotient (DQ) having one DQ≥80 and the other group DQ\<80. During the study, between 1998 and 1999, 178 ELBW neonates with a gestational age of less than 28 weeks were admitted to the NICU. 32 of them died. Of the remaining 146 neonates, 37 were excluded from the study without Criteria exclusion (affecting cognitive function and BUN) except for the feeding factor. In this group, the modified BUN was measured using the MORO formula (CBUN: BUN × 0.5 / serum creatinine). Finally, a curve of CBUN values was prepared between the days 28-84. This curve became an indicator to give extra protein. They concluded that the area under the CBUN curve could provide an estimate of whether the amount of protein given is sufficient and subsequently the evolution of preterm infants can be monitored through the CBUN level.^[@ref18]^ Radmacher et al., argued that administration of amino acids during the life's first hours might be beneficial and safe ELBW infants, leading to disappearing symptoms of renal dysfunction.^[@ref19]^ Because of disruption of organogenesis in a critical time of development, kidney size and nephron number are proved to be decreased among premature infants. This is while increased kidney injury from nephrotoxicity and hypoperfusion will give rise to structural and functional variations over time, thogh often unnoticed.^[@ref20]^ Considering the obtained P-value (P-VALUE=0.010), a significant relationship was seen between BUN and protein intake among ELBW infants. This finding is in line with results of Bush A and Fleming L,^[@ref18]^ showing that Corrected BUN (CBUN) can be an estimate of the proper amount of protein needed for growth in neonates. According to a study we did at the age of 3 years in preterm infants, protein supplementation in preterm infants had no effect on renal function, and only at the beginning of supplemental protein intake, an increased BUN was seen.^[@ref14]^ There was no significant relationship between Cr content and protein intake among ELBW infants with respect to the obtained p-value (P-VALUE=0.766), indicating no adverse effect on renal function. Unfortunately, no similar studies were found to confirm those findings. According to the obtained p-value (P-VALUE=0.257), there was a not insignificant relationship between ALB and protein intake among ELBW infants, indicating no adverse effect on renal function. For this variable, there are no similar studies. The U/A was found to be normal in both groups and no significant relationship was observed between the two groups, indicating no adverse effect on renal function. Unfortunately, no similar studies were found to confirm that finding. As in many studies, we faced limitations, including very poor resources and investigations conducted on the impact of protein supplementation on renal function of ELBW infants and also lack of collaboration from some families of patients so that only half of the capacity was employed in present study. Given the low size of the populations, this topic needs to be conducted in a greater population at diverse medical centers and hospitals, even in the entire country.

Anyhow, according to our results, protein therapy in preterm infants causes a slight increase in BUN levels. It does not affect other renal parameters such as Cr, ALB, and U/A. In conclusion, supplemental protein has no negative effect on renal function of preterm infants and does not alter renal parameters. Therefore, physicians of ELBW and VLBW infants are recommended to do not underestimate the crucial role of nutrition for their specific patients.
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:   Albumin

BUN

:   Blood Urea Nitrogen
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IRCT

:   Iranian Registry of Clinical Trials

NICU

:   Neonatal Intensive Care Unit

RCT

:   Registry of Clinical Trials

U/A
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